The present invention provides compounds which are modulators of TNF-.alpha. signaling and methods of use thereof for treating a patient having a TNF-.alpha. mediated condition. The compounds can be represented by the following structural formulas:

 
Web www.patentalert.com

< Substituted quinazolin-4-ylamine analogues

< Compounds for inflammation and immune-related uses

> Treatment of inflammatory disorders with praziquantel

> Nobel compounds having selective inhibiting effect at gsk3
~ 00280